Tag Archives: NASDAQ:EYPT

Analysts Are Bullish on Top Healthcare Stocks: EyePoint Pharmaceuticals (EYPT), RedHill Biopharma (RDHL)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on EyePoint Pharmaceuticals (EYPT – Research Report), RedHill Biopharma (RDHL – Research Report) and OncoCyte (OCX – Research Report) with bullish sentiments. EyePoint

Analysts Are Bullish on These Healthcare Stocks: EyePoint Pharmaceuticals (EYPT), Sorrento Therapeutics (SRNE)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on EyePoint Pharmaceuticals (EYPT – Research Report) and Sorrento Therapeutics (SRNE – Research Report) with bullish sentiments. EyePoint Pharmaceuticals (EYPT) In a report

EyePoint Pharmaceuticals (EYPT) Receives a Rating Update from a Top Analyst

In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on EyePoint Pharmaceuticals (EYPT – Research Report), with a price target of $15.00. The company’s shares closed last Tuesday at $9.08. According to TipRanks.com, Chen is

EyePoint Pharmaceuticals (EYPT) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on EyePoint Pharmaceuticals (EYPT – Research Report) today and set a price target of $16.00. The company’s shares closed last Thursday at $10.96. According to TipRanks.com, Chen is a top 25

B.Riley FBR Sticks to Their Hold Rating for EyePoint Pharmaceuticals (EYPT)

In a report released today, Andrew D’silva from B.Riley FBR reiterated a Hold rating on EyePoint Pharmaceuticals (EYPT – Research Report), with a price target of $0.80. The company’s shares closed last Tuesday at $0.66, close to its 52-week low

Analysts Offer Insights on Healthcare Companies: EyePoint Pharmaceuticals (NASDAQ: EYPT) and Aurinia Pharmaceuticals (NASDAQ: AUPH)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on EyePoint Pharmaceuticals (EYPT – Research Report) and Aurinia Pharmaceuticals (AUPH – Research Report). EyePoint Pharmaceuticals (EYPT) In a report released today, Yi Chen